GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback